ArticleThe Journal of surgical research2025
Thromboelastography Use: Sex, a Possible Predictor of Thrombosis in Peripheral Artery Disease.
Article in The Journal of surgical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionThrombosis of bypass grafts or stents postrevascularization procedures of lower extremities is a leading cause of amputation and higher morbidity in patients with peripheral artery disease (PAD). The aim of this study is to evaluate the relationship between sex and the risk of postrevascularization thrombosis in patients with PAD.
methodsPatient undergoing procedures between January 2021 and July 2023 underwent preoperative thromboelastography-platelet mapping (TEG-PM) analysis and were prospectively observed up to POD#60 to evaluate intervention-related thrombosis. A multivariable logistic regression analysis was carried out to assess if sex is an independent predictor of the above outcome and what specific coagulation parameters differed between the two.
resultsA total of 177 TEG-PM preoperative samples from patients were analyzed. Sixty-three (35.6%) were females. Of whom, only nine (14.2%) had >30% adenosine diphosphate-platelet inhibition, 15 (23.8%) received anticoagulation within 24 h of the intervention, and 6 (9.5%) had intervention-related thrombosis with no significant differences in baseline thrombosis risk factors. A total of 38 (21.5%) patients received anticoagulation within 24 h of the intervention. On multivariable logistic regression, females did not have a significant association with of having an intervention-related thrombotic event compared with males (odds ratio 0.19, 95% confidence interval 0.03-1.12; P = 0.067).
conclusionsThere is significant variation between the treatment patterns in patients postrevascularization. Sex may be associated with the risk of thrombosis, but this can be modulated by appropriate, individualized therapy guided by TEG-PM. A larger study population is needed to better identify the independent predictors of thrombotic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.